431 related articles for article (PubMed ID: 2408729)
1. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.
Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD
Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas.
Steinberg WM; Gelfand R; Anderson KK; Glenn J; Kurtzman SH; Sindelar WF; Toskes PP
Gastroenterology; 1986 Feb; 90(2):343-9. PubMed ID: 2416628
[TBL] [Abstract][Full Text] [Related]
3. The significance of CA19-9 tumor antigen in the serum of patients with carcinomas.
Wang FM; Tsai LC; Chang ZN; Han SH; Tsao D
Proc Natl Sci Counc Repub China B; 1985 Apr; 9(2):119-25. PubMed ID: 3863154
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
[TBL] [Abstract][Full Text] [Related]
5. [Histopathological and immunohistochemical studies on the elevation mechanism of cancer associated antigens, CEA and CA19-9, in patients with colorectal cancer].
Deguchi H; Tabuchi Y; Saitoh Y
Nihon Geka Gakkai Zasshi; 1988 May; 89(5):671-83. PubMed ID: 3166103
[TBL] [Abstract][Full Text] [Related]
6. Colon-specific antigen-p (CSAp). I. Initial clinical evaluation as a marker for colorectal cancer.
Pant KD; Shochat D; Nelson MO; Goldenberg DM
Cancer; 1982 Sep; 50(5):919-26. PubMed ID: 6178498
[TBL] [Abstract][Full Text] [Related]
7. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
Hayes DF; Zurawski VR; Kufe DW
J Clin Oncol; 1986 Oct; 4(10):1542-50. PubMed ID: 2428949
[TBL] [Abstract][Full Text] [Related]
8. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
Tappero G; Piantino P; Cerchier A; Pecchio F
Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
[TBL] [Abstract][Full Text] [Related]
9. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S
Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
[TBL] [Abstract][Full Text] [Related]
10. Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
Haglund C
Br J Cancer; 1986 Dec; 54(6):897-901. PubMed ID: 3467786
[TBL] [Abstract][Full Text] [Related]
11. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases.
Putzki H; Ledwoch J; Student A; Jablonski M; Heymann H
J Surg Oncol; 1988 Feb; 37(2):133-5. PubMed ID: 3278167
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
[TBL] [Abstract][Full Text] [Related]
13. A clinical evaluation of carbohydrate antigen 19-9 and carcinoembryonic antigen in patients with pancreatic carcinoma.
Satake K; Kanazawa G; Kho I; Chung YS; Umeyama K
J Surg Oncol; 1985 May; 29(1):15-21. PubMed ID: 3857396
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of M43: a novel cancer-associated mucin epitope.
Goodgame R; Kiefe C; Rose E; Sutton F; Brown J; Alpert E
Cancer Res; 1993 Jun; 53(12):2803-9. PubMed ID: 7684947
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen: clinical and historical aspects.
Martin EW; Kibbey WE; DiVecchia L; Anderson G; Catalano P; Minton JP
Cancer; 1976 Jan; 37(1):62-81. PubMed ID: 1247968
[TBL] [Abstract][Full Text] [Related]
16. [Serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA 19-9) values in patients with pancreatic cancer or pancreatitis].
Changchine CS; Yung CY; Tzen KY
Changgeng Yi Xue Za Zhi; 1991 Mar; 14(1):32-8. PubMed ID: 2039968
[TBL] [Abstract][Full Text] [Related]
17. [Studies on serum CEA levels measured by enzyme immunoassay using monoclonal CEA-antibodies].
Takada S; Hoshi H; Ito F; Imai K; Yachi A
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1487-91. PubMed ID: 6378102
[TBL] [Abstract][Full Text] [Related]
18. Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank.
Ritts RE; Del Villano BC; Go VL; Herberman RB; Klug TL; Zurawski VR
Int J Cancer; 1984 Mar; 33(3):339-45. PubMed ID: 6199316
[TBL] [Abstract][Full Text] [Related]
19. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.
Kuusela P; Jalanko H; Roberts P; Sipponen P; Mecklin JP; Pitkänen R; Mäkelä O
Br J Cancer; 1984 Feb; 49(2):135-9. PubMed ID: 6582896
[TBL] [Abstract][Full Text] [Related]
20. Use of four monoclonal antibodies to detect tumor markers.
Kawahara M; Terasaki PI; Chia D; Johnson C; Hermes M; Tokita K
Cancer; 1986 Nov; 58(9):2008-12. PubMed ID: 2428463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
